IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,773,128 | -34.9% | 1,845,600 | -28.1% | 0.05% | -34.3% |
| Q2 2023 | $27,301,176 | +32.8% | 2,565,900 | +31.3% | 0.07% | +32.1% |
| Q1 2023 | $20,565,548 | -3.4% | 1,954,900 | +13.7% | 0.05% | -10.2% |
| Q4 2022 | $21,297,171 | +296.3% | 1,718,900 | +231.4% | 0.06% | +268.8% |
| Q3 2022 | $5,374,000 | -27.4% | 518,700 | -19.2% | 0.02% | -23.8% |
| Q2 2022 | $7,398,000 | -18.1% | 641,600 | -10.7% | 0.02% | -12.5% |
| Q1 2022 | $9,036,000 | +709.0% | 718,300 | +649.8% | 0.02% | +700.0% |
| Q4 2021 | $1,117,000 | -85.8% | 95,800 | -84.1% | 0.00% | -85.0% |
| Q3 2021 | $7,873,000 | +410.2% | 602,857 | +403.0% | 0.02% | +400.0% |
| Q2 2021 | $1,543,000 | -69.6% | 119,857 | -73.6% | 0.00% | -71.4% |
| Q1 2021 | $5,074,000 | -29.6% | 453,857 | -28.3% | 0.01% | -26.3% |
| Q4 2020 | $7,208,000 | +8.9% | 632,857 | -14.0% | 0.02% | 0.0% |
| Q3 2020 | $6,619,000 | -35.8% | 735,857 | -26.3% | 0.02% | -36.7% |
| Q2 2020 | $10,310,000 | -11.9% | 999,057 | -13.8% | 0.03% | -33.3% |
| Q1 2020 | $11,699,000 | -34.3% | 1,159,457 | -13.4% | 0.04% | +9.8% |
| Q4 2019 | $17,815,000 | +547.8% | 1,338,457 | +317.8% | 0.04% | +485.7% |
| Q3 2019 | $2,750,000 | -21.7% | 320,357 | -0.2% | 0.01% | -22.2% |
| Q2 2019 | $3,510,000 | -19.1% | 320,857 | 0.0% | 0.01% | -18.2% |
| Q1 2019 | $4,341,000 | +871.1% | 320,857 | +643.5% | 0.01% | +1000.0% |
| Q4 2018 | $447,000 | -31.1% | 43,157 | +22.8% | 0.00% | -50.0% |
| Q3 2018 | $649,000 | -29.5% | 35,157 | -34.8% | 0.00% | -33.3% |
| Q1 2017 | $921,000 | -1.1% | 53,957 | -11.3% | 0.00% | -25.0% |
| Q4 2016 | $931,000 | -16.1% | 60,857 | -12.9% | 0.00% | -20.0% |
| Q3 2016 | $1,109,000 | +173.2% | 69,857 | +124.9% | 0.01% | +150.0% |
| Q2 2016 | $406,000 | +71.3% | 31,057 | +43.4% | 0.00% | +100.0% |
| Q1 2016 | $237,000 | -28.6% | 21,657 | -24.4% | 0.00% | -50.0% |
| Q4 2015 | $332,000 | +25.3% | 28,657 | +73.1% | 0.00% | 0.0% |
| Q1 2015 | $265,000 | +40.2% | 16,557 | +34.0% | 0.00% | +100.0% |
| Q2 2014 | $189,000 | – | 12,357 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |